These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 28925398)

  • 1. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
    Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
    Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of Axin1.
    Shen J; Yu Z; Li N
    Biochem Biophys Res Commun; 2018 Sep; 503(2):991-997. PubMed ID: 29932918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.
    Uchida C; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):157-74. PubMed ID: 26560116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities.
    Kumar S; Basu M; Ghosh MK
    Biochim Biophys Acta Mol Cell Res; 2024 Dec; 1871(8):119827. PubMed ID: 39187067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer.
    Sun A; Tian X; Chen Y; Yang W; Lin Q
    Pathol Oncol Res; 2023; 29():1610931. PubMed ID: 36825281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
    Masumoto K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of HECT E3 Ubiquitin Ligases in Colorectal Cancer.
    Sun A; Chen Y; Tian X; Lin Q
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of E3 ubiquitin ligases in gastric cancer.
    Hou YC; Deng JY
    World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation.
    Lechtenberg BC; Rajput A; Sanishvili R; Dobaczewska MK; Ware CF; Mace PD; Riedl SJ
    Nature; 2016 Jan; 529(7587):546-50. PubMed ID: 26789245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases.
    Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR
    J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HECT family of E3 ubiquitin ligases: multiple players in cancer development.
    Bernassola F; Karin M; Ciechanover A; Melino G
    Cancer Cell; 2008 Jul; 14(1):10-21. PubMed ID: 18598940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HECT-Type E3 Ubiquitin Ligases in Cancer.
    Bernassola F; Chillemi G; Melino G
    Trends Biochem Sci; 2019 Dec; 44(12):1057-1075. PubMed ID: 31610939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the Prognostic and Oncogenic Roles of Membrane-Associated Ring-CH-Type Finger 9 in Colorectal Cancer.
    Zhang J; Jiao Q; Chen Z
    Genet Res (Camb); 2024; 2024():9279653. PubMed ID: 39185021
    [No Abstract]   [Full Text] [Related]  

  • 16. E3 ubiquitin ligases as cancer targets and biomarkers.
    Sun Y
    Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.
    Wang Y; Argiles-Castillo D; Kane EI; Zhou A; Spratt DE
    J Cell Sci; 2020 Apr; 133(7):. PubMed ID: 32265230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel E3 ubiquitin ligases that regulate histone protein levels in the budding yeast Saccharomyces cerevisiae.
    Singh RK; Gonzalez M; Kabbaj MH; Gunjan A
    PLoS One; 2012; 7(5):e36295. PubMed ID: 22570702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
    Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
    Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 ubiquitin ligases in cancer and implications for therapies.
    Wang D; Ma L; Wang B; Liu J; Wei W
    Cancer Metastasis Rev; 2017 Dec; 36(4):683-702. PubMed ID: 29043469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.